Lumos Diagnostics Holdings Ltd.ASX: LDX

Economic Evaluation of FebriDx

· Issued by Lumos Diagnostics Holdings Ltd.

Filed with ASX · · 3 pages · English

• Over half the prescriptions issued during 150 million outpatient visits for acute respiratory infections (ARIs) each year in the U.S. are considered medically unnecessary • Antibiotic-related adverse events are responsible for 16% of all outpatient adverse drug consultations • Outpatient visits accounted for the majority of the US$8.8 billion antibiotic-related expenditure in the U.S. in 2015 •

Lumos Diagnostics Holdings Ltd. on 6ix

Earlier from Lumos Diagnostics

Later from Lumos Diagnostics

All Lumos Diagnostics news releases